News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
338,711 Results
Type
Article (12411)
Company Profile (24)
Press Release (326276)
Section
Business (137303)
Career Advice (782)
Deals (25276)
Drug Delivery (39)
Drug Development (34334)
Employer Resources (49)
FDA (6120)
Job Trends (7265)
News (201805)
Policy (13914)
Tag
Academia (635)
Alliances (20502)
Alzheimer's disease (558)
Approvals (6131)
Artificial intelligence (45)
Bankruptcy (269)
Best Places to Work (6073)
Breast cancer (82)
Cancer (645)
Career advice (679)
Cell therapy (139)
Clinical research (28262)
Collaboration (190)
Compensation (54)
COVID-19 (853)
C-suite (57)
Data (693)
Diabetes (64)
Diagnostics (2935)
Earnings (83191)
Employer resources (46)
Events (45707)
Executive appointments (255)
FDA (6454)
Funding (327)
Gene therapy (86)
GLP-1 (256)
Government (1408)
Healthcare (8932)
Infectious disease (889)
Inflammatory bowel disease (53)
Interviews (152)
IPO (13499)
Job creations (1442)
Job search strategy (572)
Layoffs (235)
Legal (3492)
Lung cancer (81)
Manufacturing (90)
Medical device (7073)
Medtech (7074)
Mergers & acquisitions (11930)
Metabolic disorders (189)
Neuroscience (677)
NextGen Class of 2024 (3273)
Non-profit (1276)
Northern California (904)
Obesity (98)
Opinion (123)
Patents (59)
People (28011)
Phase I (8310)
Phase II (12804)
Phase III (10043)
Pipeline (417)
Postmarket research (718)
Preclinical (3057)
Radiopharmaceuticals (141)
Rare diseases (109)
Real estate (1889)
Regulatory (9625)
Research institute (613)
Resumes & cover letters (84)
Series A (65)
Series B (47)
Southern California (868)
Startups (2685)
United States (8510)
Vaccines (214)
Weight loss (59)
Date
Last 7 days (107)
Last 30 days (859)
Last 365 days (19575)
2025 (54)
2024 (19953)
2023 (23105)
2022 (27685)
2021 (29563)
2020 (28184)
2019 (22284)
2018 (16996)
2017 (17908)
2016 (15451)
2015 (19192)
2014 (14400)
2013 (11553)
2012 (12250)
2011 (12477)
2010 (11761)
Location
Africa (288)
Arizona (74)
Asia (18725)
Australia (2873)
California (2101)
Canada (894)
China (99)
Colorado (95)
Connecticut (104)
Europe (42137)
Florida (368)
Georgia (91)
Illinois (182)
Indiana (110)
Maine (50)
Maryland (335)
Massachusetts (1419)
Michigan (131)
Minnesota (160)
New Jersey (698)
New York (711)
North Carolina (462)
Northern California (904)
Ohio (68)
Pennsylvania (526)
South America (487)
Southern California (868)
Texas (324)
Utah (71)
Washington State (275)
338,711 Results for "fina biosolutions llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development
October 29, 2024
·
3 min read
Lone Star Bio
Fina Biosolutions Selects Scorpius BioManufacturing for Production of cGMP CRM197
Fina Biosolutions has selected Scorpius BioManufacturing, a biologics contract development and manufacturing organization, for the production of an E.coli-expressed CRM197 conjugate vaccine carrier protein.
July 27, 2023
·
3 min read
Press Releases
Emergent BioSolutions Reports Third Quarter 2024 Financial Results
November 7, 2024
·
41 min read
Business
Emergent BioSolutions Reports First Quarter 2024 Financial Results
Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the first quarter ended March 31, 2024.
May 1, 2024
·
31 min read
Business
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2023.
March 6, 2024
·
39 min read
BioCapital
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
Emergent BioSolutions announced the next phase of its new operational plan that consolidates operations, closes several manufacturing facilities, and restructures its enterprise workforce to improve the performance and profitability of its business.
May 1, 2024
·
4 min read
Press Releases
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024
October 24, 2024
·
1 min read
Press Releases
Olfactive Biosolutions Establishes Scientific Advisory Board
October 29, 2024
·
3 min read
BioCapital
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
Emergent BioSolutions Inc. announced that it has entered into a “Consent, Waiver and Seventh Amendment” to its existing credit facility.
April 30, 2024
·
2 min read
Press Releases
Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
September 4, 2024
·
5 min read
1 of 33,872
Next
